医学
格雷夫斯病
疾病
重症监护医学
儿科
梅德林
内科学
法学
政治学
作者
Anna Rothenfusser,Ana Chiesa,Patricia Papendieck
标识
DOI:10.1515/jpem-2024-0394
摘要
Graves' disease is the leading cause of hyperthyroidism in children. Only a small percentage of pediatric patients achieve remission with anti-thyroid drug treatment (ATD), and both definitive therapies (thyroidectomy, or radioiodine thyroid ablation) cause lifelong hypothyroidism. Our objective was to evaluate the outcome of patients with pediatric Graves' disease (PGD), treated at a single tertiary center, focusing on response to medical treatment, remission rate, adverse reactions (AR), definitive treatment (DT), and potential predictive factors for remission.
科研通智能强力驱动
Strongly Powered by AbleSci AI